Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma

Institute of Hematology & Blood Diseases Hospital, China · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
lymphomarelapse
lymphomas non-hodgkin's b-cell, relapse, lymphoma, non-hodgkin, b-cell, cd19 car t cells, refractory, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 865026
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.